AirSculpt Technologies Inc

AirSculpt Technologies Inc(AIRS)股票分析

$1.270

+0.109 (+8.55%)收盘时

Loading chart…
最高
1.290
开盘
1.180
成交量加权均价
1.24
成交量
645.22K
市值
236.04M
最低
1.175
成交额
803.29K
企业价值/息税折旧摊销前利润(TTM)
11.37

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.

AI 分析 of AirSculpt Technologies Inc (AIRS)

持有

Airsculpt Technologies Inc is not a strong buy right now due to its current price of $1.20, which is significantly below its analyst price target of $5, indicating potential upside. However, the RSI of 16.316 suggests the stock is oversold, which could indicate a potential rebound. The main risk is its recent performance, with a 1-year change of -89.70%, indicating significant volatility and potential instability.

估值指标

AirSculpt Technologies Inc(AIRS)当前预期市盈率为 0.00,5 年平均预期市盈率为 63.22。

预期市盈率

合理
5 年均值 P/E
63.22
当前P/E
0.00
高估
358.74
低估
-232.30

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
18.53
当前EV/EBITDA
11.37
高估
38.11
低估
-1.05

预期市销率

低估
5 年均值 P/S
2.01
当前P/S
0.56
高估
3.06
低估
0.95

Alphio AI 对 AIRS 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%AIRS

$4.14

情景价格

基

基准

基准 · 50%AIRS

$3.25

情景价格

悲

悲观

悲观 · 25%AIRS

$2.81

情景价格

事件时间线

2026-08-10 (ET)

06:30:00

2026 Revenue Consensus at $153.19M, Adjusted EBITDA View Reduced to $12M-$14M

06:30:00

Company Reports Q2 Revenue of $42.9M, Below Expectations

2026-05-08 (ET)

06:40:00

Reaffirms FY26 Adjusted EBITDA View of $15M-$17M

06:40:00

AirSculpt Reports Q1 Revenue of $39.39M

2026-04-02 (ET)

16:40:00

Major U.S. Averages Mixed as Oil Prices Rise to $111.54

资讯

AIRS 常见问题 —— 由 Alphio AI 解答

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Airsculpt Technologies Inc is not a strong buy right now due to its current price of $1.20, which is significantly below its analyst price target of $5, indicating potential upside. However, the RSI of 16.316 suggests the stock is oversold, which could indicate a potential rebound. The main risk is its recent performance, with a 1-year change of -89.70%, indicating significant volatility and potential instability.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易